Merck , known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of a new, investigational intravenous formulation of NOXAFILA .
http://ift.tt/1xziyoH
http://ift.tt/1xziyoH
No comments:
Post a Comment